SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases
- PMID: 14767982
- PMCID: PMC7165792
- DOI: 10.1002/hep.20111
SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases
Abstract
Liver impairment is commonly reported in up to 60% of patients who suffer from severe acute respiratory syndrome (SARS). Here we report the clinical course and liver pathology in three SARS patients with liver impairment. Three patients who fulfilled the World Health Organization case definition of probable SARS and developed marked elevation of alanine aminotransferase were included. Percutaneous liver biopsies were performed. Liver specimens were examined by light and electron microscopy, and immunohistochemistry. Reverse-transcriptase polymerase chain reaction (RT-PCR) using enhanced real-time PCR was applied to look for evidence of SARS-associated coronavirus infection. Marked accumulation of cells in mitosis was observed in two patients and apoptosis was observed in all three patients. Other common pathologic features included ballooning of hepatocytes and mild to moderate lobular lymphocytic infiltration. No eosinophilic infiltration, granuloma, cholestasis, fibrosis, or fibrin deposition was noted. Immunohistochemical studies revealed 0.5% to 11.4% of nuclei were positive for proliferative antigen Ki-67. RT-PCR showed evidence of SARS-associated coronavirus in the liver tissues, but not in the sera of all 3 patients. However, electron microscopy could not identify viral particles. No giant mitochondria, micro- or macro-vesicular steatosis was observed. In conclusion, hepatic impairment in patients with SARS is due to SARS-associated coronavirus infection of the liver. The prominence of mitotic activity of hepatocytes is unique and may be due to a hyperproliferative state with or without disruption of cell cycle by the coronavirus. With better knowledge of pathogenesis, specific therapy may be targeted to reduce viral replication and modify the disease course.
Figures
Comment in
-
Severe acute respiratory syndrome and the liver.Hepatology. 2004 Feb;39(2):291-4. doi: 10.1002/hep.20069. Hepatology. 2004. PMID: 14767979 Free PMC article. Review. No abstract available.
Similar articles
-
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.Thorax. 2004 Mar;59(3):252-6. doi: 10.1136/thorax.2003.012658. Thorax. 2004. PMID: 14985565 Free PMC article. Clinical Trial.
-
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11. J Hepatol. 2020. PMID: 32437830 Free PMC article.
-
[Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies].Zhonghua Bing Li Xue Za Zhi. 2005 Oct;34(10):656-60. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16536279 Chinese.
-
SARS: pharmacotherapy.Respirology. 2003 Nov;8 Suppl:S25-30. doi: 10.1046/j.1440-1843.2003.00525.x. Respirology. 2003. PMID: 15018130 Review.
-
[Lopinavir/ritonavir in patients with human immunodeficiency virus infection in special situations].Enferm Infecc Microbiol Clin. 2014 Nov;32 Suppl 3:18-21. doi: 10.1016/S0213-005X(14)70163-6. Enferm Infecc Microbiol Clin. 2014. PMID: 25542871 Review. Spanish.
Cited by
-
Association between acute liver injury & severity and mortality of COVID-19 patients: A systematic review and meta-analysis.Heliyon. 2023 Sep 20;9(9):e20338. doi: 10.1016/j.heliyon.2023.e20338. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809564 Free PMC article.
-
COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.Biomed Res Int. 2023 Aug 29;2023:1879554. doi: 10.1155/2023/1879554. eCollection 2023. Biomed Res Int. 2023. PMID: 37674935 Free PMC article. Review.
-
Drawing Parallels between SARS, MERS, and COVID-19: A Comparative Overview of Epidemiology, Pathogenesis, and Pathological Features.Indian J Community Med. 2023 Jul-Aug;48(4):518-524. doi: 10.4103/ijcm.ijcm_460_22. Epub 2023 Jul 14. Indian J Community Med. 2023. PMID: 37662119 Free PMC article. Review.
-
Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines.Front Endocrinol (Lausanne). 2023 Aug 15;14:1139692. doi: 10.3389/fendo.2023.1139692. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37654571 Free PMC article. Review.
-
Liver and Renal Impairments in COVID-19 Patients of Madinah City of Saudi Arabia: A Cross-Sectional Study (2020).Cureus. 2023 May 23;15(5):e39409. doi: 10.7759/cureus.39409. eCollection 2023 May. Cureus. 2023. PMID: 37362525 Free PMC article.
References
-
- Holmes KV, Lai MMC. Coronaviridae and their replication. In: Fields B, Knipe D, Howley P, eds. Fields virology. 3rd edition. Philadelphia: Lippincott‐Raven, 1996: 1075.
-
- Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967–1976. - PubMed
-
- Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986–1994. - PubMed
-
- Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan‐Yeung M, Lam WK, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1977–1985. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous